| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.907 | 0.003 | 0.907 | Aldehyde oxidase inhibitor | 0.223 0.093 CID_154699617 | ||
| 0.718 | 0.004 | 0.718 | Superoxide dismutase inhibitor | 0.176 0.146 CID_154699617 | ||
| 0.684 | 0.009 | 0.846 | Cholesterol antagonist | 0.846 0.003 CID_154699617 | CID_154699617 | |
| 0.645 | 0.011 | 0.645 | 5 Hydroxytryptamine release stimulant | 0.47 0.032 CID_154699617 | ||
| 0.625 | 0.005 | 0.625 | GABA C receptor rho-3 antagonist | |||
| 0.596 | 0.005 | 0.596 | Peroxidase inhibitor | |||
| 0.619 | 0.048 | 0.853 | Antiinflammatory | 0.853 0.009 CID_154699617 | CID_154699617 | |
| 0.562 | 0.003 | 0.562 | Alcohol oxidase inhibitor | 0.062 0.034 CID_154699617 | ||
| 0.57 | 0.013 | 0.699 | Histamine release inhibitor | 0.699 0.005 CID_154699617 | CID_154699617 | |
| 0.574 | 0.04 | 0.574 | Caspase 9 stimulant | 0.541 0.047 CID_154699617 | ||
| 0.545 | 0.02 | 0.613 | 5 Hydroxytryptamine release inhibitor | 0.613 0.009 CID_154699617 | CID_154699617 | |
| 0.535 | 0.016 | 0.739 | Antioxidant | 0.739 0.005 CID_154699617 | CID_154699617 | |
| 0.493 | 0.005 | 0.493 | Lipid peroxidase inhibitor | 0.488 0.005 CID_154699617 | ||
| 0.493 | 0.008 | 0.493 | Anesthetic general | 0.474 0.01 CID_154699617 | ||
| 0.483 | 0.004 | 0.483 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.474 | 0.006 | 0.702 | Alpha-N-acetylglucosaminidase inhibitor | 0.702 0.003 CID_154699617 | CID_154699617 | |
| 0.468 | 0.005 | 0.503 | NOS3 expression enhancer | 0.503 0.005 CID_154699617 | CID_154699617 | |
| 0.478 | 0.018 | 0.664 | Free radical scavenger | 0.664 0.006 CID_154699617 | CID_154699617 | |
| 0.491 | 0.038 | 0.491 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.457 | 0.006 | 0.457 | 5 Hydroxytryptamine uptake stimulant | 0.201 0.15 CID_154699617 | ||
| 0.468 | 0.023 | 0.468 | Lipoxygenase inhibitor | |||
| 0.444 | 0.003 | 0.444 | Ferrochelatase inhibitor | 0.141 0.042 CID_154699617 | ||
| 0.446 | 0.009 | 0.634 | Melanin inhibitor | 0.634 0.004 CID_154699617 | CID_154699617 | |
| 0.473 | 0.039 | 0.473 | Calcium channel L-type activator | |||
| 0.439 | 0.005 | 0.439 | Vanilloid 1 antagonist | |||
| 0.486 | 0.053 | 0.486 | Analgesic | |||
| 0.436 | 0.005 | 0.45 | Neurotrophic factor enhancer | 0.45 0.004 CID_154699617 | CID_154699617 | |
| 0.43 | 0.004 | 0.43 | Vanilloid agonist | 0.128 0.015 CID_154699617 | ||
| 0.457 | 0.038 | 0.457 | Vasodilator, peripheral | 0.437 0.044 CID_154699617 | ||
| 0.395 | 0.005 | 0.395 | 5-Lipoxygenase inhibitor | |||
| 0.388 | 0.004 | 0.388 | TRPA1 agonist | 0.199 0.011 CID_154699617 | ||
| 0.379 | 0.004 | 0.473 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.473 0.003 CID_154699617 | CID_154699617 | |
| 0.408 | 0.042 | 0.408 | Caspase 3 stimulant | 0.399 0.045 CID_154699617 | ||
| 0.383 | 0.018 | 0.383 | ErbB-1 antagonist | |||
| 0.42 | 0.059 | 0.72 | Transcription factor NF kappa B inhibitor | 0.72 0.018 CID_154699617 | CID_154699617 | |
| 0.364 | 0.004 | 0.364 | Estrogen receptor beta antagonist | |||
| 0.367 | 0.013 | 0.367 | Phospholipase C inhibitor | 0.263 0.023 CID_154699617 | ||
| 0.357 | 0.005 | 0.357 | Estrogen antagonist | |||
| 0.384 | 0.034 | 0.417 | Hypoxia-inducible factor 1 alpha inhibitor | 0.417 0.026 CID_154699617 | CID_154699617 | |
| 0.406 | 0.072 | 0.406 | 15-Lipoxygenase inhibitor | |||
| 0.371 | 0.037 | 0.371 | Calcium channel activator | |||
| 0.363 | 0.032 | 0.363 | Sodium/bile acid cotransporter inhibitor | 0.271 0.107 CID_154699617 | ||
| 0.331 | 0.004 | 0.331 | Creatine kinase inhibitor | |||
| 0.334 | 0.009 | 0.334 | Aldehyde dehydrogenase inhibitor | 0.289 0.013 CID_154699617 | ||
| 0.357 | 0.034 | 0.447 | Hypolipemic | 0.447 0.018 CID_154699617 | CID_154699617 | |
| 0.376 | 0.054 | 0.376 | Streptokinase A inhibitor | |||
| 0.422 | 0.104 | 0.646 | Apoptosis agonist | 0.646 0.04 CID_154699617 | CID_154699617 | |
| 0.323 | 0.007 | 0.323 | Interleukin 4 antagonist | 0.208 0.02 CID_154699617 | ||
| 0.323 | 0.012 | 0.323 | Cyclooxygenase 1 inhibitor | 0.17 0.048 CID_154699617 | ||
| 0.313 | 0.005 | 0.313 | Porphobilinogen synthase inhibitor | |||
| 0.31 | 0.005 | 0.325 | Mannose-6-phosphate isomerase inhibitor | 0.325 0.004 CID_154699617 | CID_154699617 | |
| 0.31 | 0.005 | 0.31 | Farnesoid X receptor antagonist | 0.131 0.081 CID_154699617 | ||
| 0.342 | 0.04 | 0.342 | Interleukin antagonist | |||
| 0.308 | 0.009 | 0.308 | Succinate dehydrogenase inhibitor | 0.172 0.077 CID_154699617 | ||
| 0.336 | 0.038 | 0.336 | Pyruvate kinase inhibitor | |||
| 0.3 | 0.005 | 0.3 | Estrogen agonist | 0.088 0.02 CID_154699617 | ||
| 0.31 | 0.018 | 0.485 | Interferon gamma antagonist | 0.485 0.007 CID_154699617 | CID_154699617 | |
| 0.318 | 0.028 | 0.318 | RNA-directed DNA polymerase inhibitor | 0.256 0.046 CID_154699617 | ||
| 0.296 | 0.012 | 0.296 | Cholesterol synthesis inhibitor | 0.222 0.022 CID_154699617 | ||
| 0.294 | 0.01 | 0.294 | Cystathionine beta-synthase inhibitor | 0.248 0.015 CID_154699617 | ||
| 0.321 | 0.037 | 0.482 | DNA synthesis inhibitor | 0.482 0.015 CID_154699617 | CID_154699617 | |
| 0.297 | 0.014 | 0.297 | Adenylate cyclase inhibitor | 0.192 0.027 CID_154699617 | ||
| 0.305 | 0.022 | 0.305 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.228 0.053 CID_154699617 | ||
| 0.284 | 0.002 | 0.284 | Estrogen-related receptor beta agonist | 0.095 0.031 CID_154699617 | ||
| 0.294 | 0.013 | 0.294 | Nitric-oxide synthase stimulant | 0.293 0.013 CID_154699617 | ||
| 0.283 | 0.004 | 0.283 | CF transmembrane conductance regulator agonist | 0.211 0.016 CID_154699617 | ||
| 0.339 | 0.061 | 0.53 | Vasodilator, coronary | 0.53 0.012 CID_154699617 | CID_154699617 | |
| 0.335 | 0.057 | 0.455 | Spasmolytic | 0.455 0.03 CID_154699617 | CID_154699617 | |
| 0.281 | 0.005 | 0.281 | GABA C receptor antagonist | |||
| 0.287 | 0.011 | 0.459 | UDP-glucose 4-epimerase inhibitor | 0.459 0.004 CID_154699617 | CID_154699617 | |
| 0.319 | 0.047 | 0.736 | Hypoglycemic | 0.736 0.005 CID_154699617 | CID_154699617 | |
| 0.294 | 0.022 | 0.294 | Neuropeptide Y2 antagonist | |||
| 0.283 | 0.012 | 0.443 | Hexokinase inhibitor | 0.443 0.004 CID_154699617 | CID_154699617 | |
| 0.284 | 0.015 | 0.284 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.353 | 0.085 | 0.353 | Calpain 2 inhibitor | |||
| 0.269 | 0.012 | 0.269 | GABA C receptor agonist | |||
| 0.343 | 0.09 | 0.558 | Immunosuppressant | 0.558 0.019 CID_154699617 | CID_154699617 | |
| 0.274 | 0.021 | 0.553 | Monophenol monooxygenase inhibitor | 0.553 0.006 CID_154699617 | CID_154699617 | |
| 0.257 | 0.004 | 0.257 | Adenylate cyclase stimulant | 0.187 0.021 CID_154699617 | ||
| 0.326 | 0.074 | 0.747 | Antithrombotic | 0.747 0.006 CID_154699617 | CID_154699617 | |
| 0.32 | 0.069 | 0.32 | 12-Lipoxygenase inhibitor | |||
| 0.283 | 0.032 | 0.558 | Non-steroidal antiinflammatory agent | 0.558 0.005 CID_154699617 | CID_154699617 | |
| 0.303 | 0.054 | 0.303 | Transcription factor STAT inhibitor | |||
| 0.255 | 0.011 | 0.255 | GABA C receptor rho-2 antagonist | |||
| 0.249 | 0.005 | 0.249 | Electron transport complex I inhibitor | 0.119 0.048 CID_154699617 | ||
| 0.247 | 0.005 | 0.247 | Vanilloid 1 agonist | 0.219 0.008 CID_154699617 | ||
| 0.265 | 0.024 | 0.575 | Amylase inhibitor | 0.575 0.004 CID_154699617 | CID_154699617 | |
| 0.247 | 0.006 | 0.247 | Arachidonic acid antagonist | 0.207 0.027 CID_154699617 | ||
| 0.258 | 0.024 | 0.438 | Protein kinase stimulant | 0.438 0.006 CID_154699617 | CID_154699617 | |
| 0.232 | 0.004 | 0.232 | DOPA decarboxylase inhibitor | |||
| 0.284 | 0.057 | 0.43 | Interleukin agonist | 0.43 0.015 CID_154699617 | CID_154699617 | |
| 0.228 | 0.005 | 0.228 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.304 | 0.083 | 0.546 | Apoptosis antagonist | 0.546 0.015 CID_154699617 | CID_154699617 | |
| 0.244 | 0.028 | 0.244 | Histone acetyltransferase inhibitor | |||
| 0.284 | 0.069 | 0.284 | Insulysin inhibitor | |||
| 0.223 | 0.011 | 0.223 | Histidine decarboxylase inhibitor | |||
| 0.238 | 0.026 | 0.238 | Cytokine production inhibitor | |||
| 0.217 | 0.006 | 0.217 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.218 | 0.007 | 0.218 | Pregnane X receptor agonist | |||
| 0.238 | 0.029 | 0.238 | Cyclooxygenase inhibitor | 0.145 0.074 CID_154699617 | ||
| 0.273 | 0.064 | 0.532 | Tumour necrosis factor alpha release inhibitor | 0.532 0.011 CID_154699617 | CID_154699617 | |
| 0.215 | 0.007 | 0.215 | Keratolytic | |||
| 0.215 | 0.01 | 0.317 | Photosensitizer | 0.317 0.004 CID_154699617 | CID_154699617 | |
| 0.208 | 0.004 | 0.208 | Glycine receptor agonist | 0.183 0.005 CID_154699617 | ||
| 0.206 | 0.003 | 0.206 | Vanilloid 2 antagonist | 0.051 0.039 CID_154699617 | ||
| 0.321 | 0.12 | 0.655 | Antibacterial | 0.655 0.013 CID_154699617 | CID_154699617 | |
| 0.234 | 0.036 | 0.234 | Tumour necrosis factor antagonist | |||
| 0.21 | 0.011 | 0.222 | Mucolytic | 0.222 0.009 CID_154699617 | CID_154699617 | |
| 0.253 | 0.057 | 0.253 | Amyloid beta aggregation inhibitor | 0.138 0.118 CID_154699617 | ||
| 0.201 | 0.004 | 0.201 | Estrogen receptor alpha agonist | |||
| 0.2 | 0.004 | 0.2 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.26 | 0.064 | 0.26 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.198 | 0.004 | 0.198 | CC chemokine 6 receptor antagonist | 0.193 0.004 CID_154699617 | ||
| 0.198 | 0.005 | 0.198 | Ornithine decarboxylase inhibitor | 0.158 0.009 CID_154699617 | ||
| 0.236 | 0.043 | 0.236 | Insulin sensitizer | 0.232 0.046 CID_154699617 | ||
| 0.201 | 0.007 | 0.201 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.203 | 0.01 | 0.413 | Triose-phosphate isomerase inhibitor | 0.413 0.003 CID_154699617 | CID_154699617 | |
| 0.195 | 0.004 | 0.195 | Bile acid receptor antagonist | 0.122 0.018 CID_154699617 | ||
| 0.195 | 0.005 | 0.195 | Estrogen receptor beta agonist | 0.028 0.024 CID_154699617 | ||
| 0.208 | 0.017 | 0.208 | Carbonic anhydrase XV inhibitor | |||
| 0.276 | 0.086 | 0.551 | Immunostimulant | 0.551 0.022 CID_154699617 | CID_154699617 | |
| 0.263 | 0.074 | 0.263 | Transcription factor STAT3 inhibitor | |||
| 0.197 | 0.009 | 0.197 | Prolactin inhibitor | |||
| 0.193 | 0.007 | 0.193 | Glutamate decarboxylase inhibitor | |||
| 0.215 | 0.029 | 0.215 | Nav1.2 sodium channel blocker | |||
| 0.252 | 0.069 | 0.822 | Angiogenesis stimulant | 0.822 0.004 CID_154699617 | CID_154699617 | |
| 0.325 | 0.142 | 0.844 | Cyclophilin D inhibitor | 0.844 0.005 CID_154699617 | CID_154699617 | |
| 0.187 | 0.005 | 0.187 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.193 | 0.01 | 0.193 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.235 | 0.053 | 0.327 | DNA methyltransferase I inhibitor | 0.327 0.018 CID_154699617 | CID_154699617 | |
| 0.214 | 0.032 | 0.214 | Heat shock protein 90 antagonist | |||
| 0.201 | 0.02 | 0.533 | Expectorant | 0.533 0.003 CID_154699617 | CID_154699617 | |
| 0.201 | 0.023 | 0.201 | Toll-Like receptor 2 antagonist | |||
| 0.183 | 0.006 | 0.183 | Ca2+-transporting ATPase inhibitor | 0.177 0.008 CID_154699617 | ||
| 0.188 | 0.011 | 0.383 | NADH dehydrogenase inhibitor | 0.383 0.005 CID_154699617 | CID_154699617 | |
| 0.208 | 0.031 | 0.345 | ATPase inhibitor | 0.345 0.004 CID_154699617 | CID_154699617 | |
| 0.19 | 0.014 | 0.19 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.194 | 0.017 | 0.194 | Carbonic anhydrase III inhibitor | 0.104 0.058 CID_154699617 | ||
| 0.185 | 0.009 | 0.185 | Macrophage migration inhibitory factor inhibitor | |||
| 0.216 | 0.041 | 0.216 | Heat shock protein 90 alpha antagonist | |||
| 0.206 | 0.032 | 0.206 | Neurotensin receptor agonist | |||
| 0.23 | 0.057 | 0.493 | Nitric oxide antagonist | 0.493 0.016 CID_154699617 | CID_154699617 | |
| 0.188 | 0.017 | 0.188 | Adenylate kinase inhibitor | 0.151 0.026 CID_154699617 | ||
| 0.209 | 0.038 | 0.209 | Phospholipase A2 inhibitor | 0.183 0.052 CID_154699617 | ||
| 0.191 | 0.021 | 0.191 | Nav1.1 sodium channel blocker | |||
| 0.207 | 0.037 | 0.301 | Interleukin 6 antagonist | 0.301 0.014 CID_154699617 | CID_154699617 | |
| 0.199 | 0.03 | 0.393 | Cell wall synthesis inhibitor | 0.393 0.006 CID_154699617 | CID_154699617 | |
| 0.18 | 0.012 | 0.18 | GABA C receptor rho-1 antagonist | |||
| 0.211 | 0.046 | 0.211 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.267 | 0.101 | 0.466 | Interleukin 2 agonist | 0.466 0.013 CID_154699617 | CID_154699617 | |
| 0.189 | 0.023 | 0.515 | Cyclooxygenase 3 inhibitor | 0.515 0.003 CID_154699617 | CID_154699617 | |
| 0.19 | 0.025 | 0.19 | Cathepsin H inhibitor | |||
| 0.173 | 0.009 | 0.173 | Anabolic | 0.119 0.04 CID_154699617 | ||
| 0.187 | 0.023 | 0.187 | Interleukin 1b antagonist | 0.135 0.051 CID_154699617 | ||
| 0.176 | 0.012 | 0.176 | ABCA1 expression enhancer | |||
| 0.175 | 0.011 | 0.175 | Transcription factor STAT6 inhibitor | |||
| 0.182 | 0.019 | 0.182 | Catalase inhibitor | |||
| 0.238 | 0.076 | 0.238 | Calpain inhibitor | |||
| 0.163 | 0.003 | 0.163 | Squalene epoxidase inhibitor | 0.08 0.009 CID_154699617 | ||
| 0.163 | 0.004 | 0.163 | GABA B receptor agonist | |||
| 0.156 | 0.003 | 0.156 | Adenine nucleotide translocase inhibitor | 0.123 0.004 CID_154699617 | ||
| 0.19 | 0.038 | 0.19 | Interleukin 1 antagonist | |||
| 0.169 | 0.018 | 0.169 | Sphingomyelinase inhibitor | 0.156 0.022 CID_154699617 | ||
| 0.159 | 0.008 | 0.159 | Leukotriene synthesis inhibitor | |||
| 0.175 | 0.027 | 0.23 | Microtubule formation inhibitor | 0.23 0.014 CID_154699617 | CID_154699617 | |
| 0.177 | 0.03 | 0.177 | Nav1.6 sodium channel blocker | |||
| 0.198 | 0.053 | 0.412 | Thrombolytic | 0.412 0.01 CID_154699617 | CID_154699617 | |
| 0.156 | 0.011 | 0.156 | Estrogen receptor alpha antagonist | |||
| 0.153 | 0.009 | 0.167 | Glutamate release inhibitor | 0.167 0.007 CID_154699617 | CID_154699617 | |
| 0.165 | 0.022 | 0.17 | Heat shock protein 70 antagonist | 0.17 0.017 CID_154699617 | CID_154699617 | |
| 0.19 | 0.048 | 0.413 | Diuretic | 0.413 0.012 CID_154699617 | CID_154699617 | |
| 0.154 | 0.012 | 0.154 | Beta tubulin antagonist | |||
| 0.146 | 0.004 | 0.146 | CC chemokine 5 receptor agonist | |||
| 0.232 | 0.091 | 0.26 | DNA damaging | 0.26 0.075 CID_154699617 | CID_154699617 | |
| 0.152 | 0.012 | 0.153 | Interleukin 12 antagonist | 0.153 0.011 CID_154699617 | CID_154699617 | |
| 0.144 | 0.004 | 0.144 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.211 | 0.072 | 0.327 | DNA methylase inhibitor | 0.327 0.021 CID_154699617 | CID_154699617 | |
| 0.167 | 0.028 | 0.256 | Xanthine oxidase inhibitor | 0.256 0.011 CID_154699617 | CID_154699617 | |
| 0.142 | 0.005 | 0.142 | Plasminogen activator inhibitor antagonist | |||
| 0.184 | 0.047 | 0.184 | Catenin beta inhibitor | |||
| 0.235 | 0.098 | 0.235 | Gastrin inhibitor | 0.193 0.159 CID_154699617 | ||
| 0.141 | 0.005 | 0.141 | Heat shock protein 90 beta antagonist | |||
| 0.205 | 0.069 | 0.483 | Platelet adhesion inhibitor | 0.483 0.006 CID_154699617 | CID_154699617 | |
| 0.2 | 0.065 | 0.549 | Hepatoprotectant | 0.549 0.005 CID_154699617 | CID_154699617 | |
| 0.138 | 0.003 | 0.138 | Dopamine beta hydroxylase inhibitor | |||
| 0.152 | 0.018 | 0.27 | Phosphofructokinase-1 inhibitor | 0.27 0.006 CID_154699617 | CID_154699617 | |
| 0.153 | 0.02 | 0.153 | Vanilloid antagonist | |||
| 0.164 | 0.032 | 0.164 | Aminopeptidase B inhibitor | |||
| 0.14 | 0.007 | 0.14 | D-Ala-D-Ala ligase inhibitor | |||
| 0.219 | 0.087 | 0.307 | Antiamyloidogenic | 0.307 0.049 CID_154699617 | CID_154699617 | |
| 0.157 | 0.026 | 0.157 | Potassium channel (Ca-activated) activator | |||
| 0.141 | 0.01 | 0.141 | TRPA1 antagonist | |||
| 0.157 | 0.028 | 0.157 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.159 | 0.029 | 0.159 | Interleukin 8 antagonist | |||
| 0.149 | 0.02 | 0.149 | Opioid delta receptor antagonist | |||
| 0.172 | 0.043 | 0.172 | NADPH oxidase inhibitor | 0.123 0.079 CID_154699617 | ||
| 0.132 | 0.005 | 0.132 | Kinesin-like protein 1 inhibitor | |||
| 0.132 | 0.005 | 0.132 | Kinesin antagonist | |||
| 0.129 | 0.003 | 0.129 | Dopamine D5 agonist | |||
| 0.148 | 0.022 | 0.194 | Toll-Like receptor 4 antagonist | 0.194 0.007 CID_154699617 | CID_154699617 | |
| 0.189 | 0.064 | 0.189 | Lipocortins synthesis antagonist | 0.169 0.081 CID_154699617 | ||
| 0.14 | 0.015 | 0.14 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.134 | 0.009 | 0.134 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.149 | 0.026 | 0.149 | Opioid antagonist | |||
| 0.17 | 0.049 | 0.17 | Tubulin antagonist | |||
| 0.136 | 0.015 | 0.136 | Aromatase inhibitor | |||
| 0.133 | 0.012 | 0.133 | GABA aminotransferase inhibitor | 0.118 0.017 CID_154699617 | ||
| 0.148 | 0.029 | 0.148 | Caspase 3 inhibitor | |||
| 0.128 | 0.01 | 0.128 | Purinergic P2X1 antagonist | 0.065 0.036 CID_154699617 | ||
| 0.129 | 0.011 | 0.129 | Acyl-CoA dehydrogenase inhibitor | 0.069 0.027 CID_154699617 | ||
| 0.129 | 0.014 | 0.182 | Glycine receptor antagonist | 0.182 0.004 CID_154699617 | CID_154699617 | |
| 0.119 | 0.004 | 0.119 | Retinoid X alpha receptor agonist | |||
| 0.137 | 0.023 | 0.137 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.142 | 0.029 | 0.387 | Beta glucuronidase inhibitor | 0.387 0.004 CID_154699617 | CID_154699617 | |
| 0.149 | 0.036 | 0.149 | Chelator | |||
| 0.137 | 0.024 | 0.137 | Carbonic anhydrase VI inhibitor | |||
| 0.115 | 0.003 | 0.115 | Pregnane X receptor antagonist | 0.057 0.038 CID_154699617 | ||
| 0.124 | 0.013 | 0.124 | Biliverdin reductase inhibitor | 0.085 0.024 CID_154699617 | ||
| 0.135 | 0.025 | 0.14 | Carbonic anhydrase XIII inhibitor | 0.14 0.024 CID_154699617 | CID_154699617 | |
| 0.143 | 0.033 | 0.423 | AMP-activated protein kinase stimulant | 0.423 0.004 CID_154699617 | CID_154699617 | |
| 0.129 | 0.02 | 0.129 | Glutamate dehydrogenase inhibitor | 0.091 0.036 CID_154699617 | ||
| 0.113 | 0.004 | 0.113 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.157 | 0.049 | 0.157 | Cyclooxygenase 2 inhibitor | 0.104 0.099 CID_154699617 | ||
| 0.155 | 0.047 | 0.155 | Anesthetic local | |||
| 0.11 | 0.002 | 0.11 | Estrogen-related receptor gamma agonist | |||
| 0.134 | 0.027 | 0.134 | Electrolyte absorption antagonist | |||
| 0.16 | 0.052 | 0.16 | Bone formation stimulant | 0.125 0.081 CID_154699617 | ||
| 0.2 | 0.093 | 0.347 | Cyclic AMP phosphodiesterase inhibitor | 0.347 0.026 CID_154699617 | CID_154699617 | |
| 0.191 | 0.085 | 0.199 | Psychostimulant | 0.199 0.081 CID_154699617 | CID_154699617 | |
| 0.11 | 0.003 | 0.11 | Retinoid X beta receptor agonist | 0.027 0.01 CID_154699617 | ||
| 0.11 | 0.004 | 0.11 | Dihydroorotate oxidase inhibitor | |||
| 0.133 | 0.027 | 0.133 | Alcohol dehydrogenase inhibitor | 0.105 0.047 CID_154699617 | ||
| 0.124 | 0.021 | 0.124 | Interleukin 5 antagonist | 0.108 0.033 CID_154699617 | ||
| 0.109 | 0.006 | 0.109 | Sphingosine kinase 2 inhibitor | |||
| 0.113 | 0.011 | 0.113 | Glycine transporter 2 inhibitor | |||
| 0.105 | 0.004 | 0.105 | Immunoglobulin Fc receptor antagonist | |||
| 0.149 | 0.048 | 0.149 | Nav1.3 sodium channel blocker | |||
| 0.172 | 0.072 | 0.172 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.12 | 0.02 | 0.12 | Aminopeptidase I inhibitor | |||
| 0.107 | 0.008 | 0.107 | MAP kinase kinase 7 inhibitor | |||
| 0.103 | 0.004 | 0.103 | Retinoid X receptor agonist | |||
| 0.105 | 0.007 | 0.105 | Sphingosine kinase inhibitor | |||
| 0.109 | 0.012 | 0.109 | Androgen agonist | |||
| 0.141 | 0.043 | 0.141 | Alpha 2b adrenoreceptor antagonist | |||
| 0.139 | 0.043 | 0.267 | DNA repair enzyme inhibitor | 0.267 0.005 CID_154699617 | CID_154699617 | |
| 0.178 | 0.082 | 0.187 | P-glycoprotein inhibitor | 0.187 0.073 CID_154699617 | CID_154699617 | |
| 0.109 | 0.012 | 0.109 | Beta 3 adrenoreceptor antagonist | |||
| 0.102 | 0.006 | 0.102 | MDM2 inhibitor | |||
| 0.119 | 0.024 | 0.119 | Opioid kappa receptor antagonist | |||
| 0.198 | 0.102 | 0.427 | Peptidyltransferase inhibitor | 0.427 0.005 CID_154699617 | CID_154699617 | |
| 0.099 | 0.004 | 0.099 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.169 | 0.074 | 0.169 | Growth hormone agonist | |||
| 0.142 | 0.047 | 0.165 | Beta amyloid protein antagonist | 0.165 0.031 CID_154699617 | CID_154699617 | |
| 0.113 | 0.019 | 0.113 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.122 | 0.029 | 0.156 | Thioredoxin inhibitor | 0.156 0.015 CID_154699617 | CID_154699617 | |
| 0.098 | 0.005 | 0.098 | AMPA 4 receptor antagonist | |||
| 0.099 | 0.006 | 0.099 | Calcium channel P-type blocker | |||
| 0.124 | 0.031 | 0.124 | Androgen antagonist | |||
| 0.117 | 0.026 | 0.117 | Opioid mu receptor antagonist | |||
| 0.16 | 0.069 | 0.16 | Protein-tyrosine phosphatase inhibitor | 0.16 0.069 CID_154699617 | ||
| 0.229 | 0.139 | 0.229 | Prostaglandin dehydrogenase inhibitor | |||
| 0.093 | 0.004 | 0.093 | Retinoid X gamma receptor agonist | 0.026 0.013 CID_154699617 | ||
| 0.103 | 0.014 | 0.103 | Cannabinoid CB2 receptor antagonist | |||
| 0.193 | 0.105 | 0.193 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.091 | 0.004 | 0.091 | ATP citrate lysase inhibitor | |||
| 0.182 | 0.094 | 0.182 | MAP kinase kinase 2 inhibitor | |||
| 0.104 | 0.019 | 0.104 | Carbamoyl phosphate synthetase inhibitor | 0.059 0.044 CID_154699617 | ||
| 0.264 | 0.179 | 0.522 | Alpha-glucosidase inhibitor | 0.522 0.074 CID_154699617 | CID_154699617 | |
| 0.147 | 0.062 | 0.152 | Alkaline phosphatase inhibitor | 0.152 0.058 CID_154699617 | CID_154699617 | |
| 0.103 | 0.018 | 0.103 | Argininosuccinate synthase inhibitor | 0.071 0.03 CID_154699617 | ||
| 0.131 | 0.047 | 0.131 | 5 Hydroxytryptamine 3A agonist | |||
| 0.099 | 0.015 | 0.099 | Phospholipase D inhibitor | |||
| 0.12 | 0.037 | 0.12 | Protein kinase C delta inhibitor | |||
| 0.154 | 0.072 | 0.154 | Cytidine deaminase inhibitor | |||
| 0.09 | 0.008 | 0.284 | Alpha-mannosidase inhibitor | 0.284 0.002 CID_154699617 | CID_154699617 | |
| 0.104 | 0.025 | 0.104 | Prostaglandin-E synthase inhibitor | |||
| 0.091 | 0.012 | 0.091 | NMDA receptor subunit 3B antagonist | |||
| 0.106 | 0.026 | 0.126 | Na+ K+ transporting ATPase inhibitor | 0.126 0.013 CID_154699617 | CID_154699617 | |
| 0.145 | 0.066 | 0.145 | Histone deacetylase SIRT1 inhibitor | |||
| 0.152 | 0.073 | 0.152 | Acetylcholine M1 receptor antagonist | |||
| 0.09 | 0.011 | 0.09 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.096 | 0.018 | 0.096 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.094 0.019 CID_154699617 | ||
| 0.093 | 0.015 | 0.093 | Glutamate (mGluR7) antagonist | |||
| 0.082 | 0.005 | 0.082 | Alpha 1d adrenoreceptor agonist | |||
| 0.088 | 0.011 | 0.088 | Aconitate hydratase inhibitor | |||
| 0.122 | 0.045 | 0.13 | Acetylcholine release stimulant | 0.13 0.034 CID_154699617 | CID_154699617 | |
| 0.083 | 0.007 | 0.083 | Adenylate cyclase 1 inhibitor | |||
| 0.108 | 0.032 | 0.108 | Adrenaline agonist | |||
| 0.13 | 0.056 | 0.16 | Protein-tyrosine phosphatase 1B inhibitor | 0.16 0.042 CID_154699617 | CID_154699617 | |
| 0.114 | 0.04 | 0.114 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.093 | 0.019 | 0.093 | Maillard reaction inhibitor | |||
| 0.09 | 0.017 | 0.106 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.106 0.013 CID_154699617 | CID_154699617 | |
| 0.103 | 0.03 | 0.103 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.121 | 0.047 | 0.308 | Mediator release inhibitor | 0.308 0.007 CID_154699617 | CID_154699617 | |
| 0.145 | 0.073 | 0.145 | Neuropeptide Y1 antagonist | |||
| 0.121 | 0.049 | 0.121 | Alpha 2c adrenoreceptor antagonist | |||
| 0.076 | 0.004 | 0.076 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.105 | 0.033 | 0.105 | CYP2A6 inhibitor | |||
| 0.09 | 0.019 | 0.09 | Xanthine dehydrogenase inhibitor | |||
| 0.108 | 0.038 | 0.156 | Phosphodiesterase 6D inhibitor | 0.156 0.008 CID_154699617 | CID_154699617 | |
| 0.091 | 0.021 | 0.091 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.098 | 0.029 | 0.098 | CDC25A inhibitor | |||
| 0.144 | 0.075 | 0.144 | Thiol protease inhibitor | |||
| 0.078 | 0.01 | 0.078 | Ryanodine receptor antagonist | |||
| 0.088 | 0.019 | 0.088 | Carbonic anhydrase VB inhibitor | |||
| 0.253 | 0.185 | 0.253 | Transcription factor inhibitor | |||
| 0.086 | 0.018 | 0.086 | NMDA 2A receptor antagonist | |||
| 0.08 | 0.012 | 0.08 | Potassium channel Kv1.3 blocker | |||
| 0.077 | 0.009 | 0.265 | Mannosidase inhibitor | 0.265 0.002 CID_154699617 | CID_154699617 | |
| 0.085 | 0.019 | 0.085 | Glutamate (mGluR6) antagonist | |||
| 0.088 | 0.022 | 0.088 | Beta adrenoreceptor antagonist | |||
| 0.108 | 0.042 | 0.108 | Protein kinase C zeta inhibitor | |||
| 0.086 | 0.021 | 0.086 | NMDA 2C receptor antagonist | |||
| 0.128 | 0.063 | 0.166 | DNA polymerase I inhibitor | 0.166 0.041 CID_154699617 | CID_154699617 | |
| 0.093 | 0.028 | 0.093 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.074 | 0.009 | 0.074 | Cholesterol esterase inhibitor | 0.045 0.039 CID_154699617 | ||
| 0.069 | 0.004 | 0.069 | Retinoid X receptor antagonist | |||
| 0.076 | 0.012 | 0.076 | Beta 2 adrenoreceptor agonist | |||
| 0.074 | 0.011 | 0.112 | Glucose-6-phosphate isomerase inhibitor | 0.112 0.004 CID_154699617 | CID_154699617 | |
| 0.069 | 0.006 | 0.069 | Glucagon receptor antagonist | |||
| 0.067 | 0.005 | 0.067 | Kainate receptor agonist | 0.039 0.033 CID_154699617 | ||
| 0.104 | 0.043 | 0.104 | Histamine N-methyltransferase inhibitor | |||
| 0.067 | 0.007 | 0.067 | Retinoic acid alpha receptor agonist | 0.04 0.026 CID_154699617 | ||
| 0.15 | 0.09 | 0.15 | Mcl-1 antagonist | |||
| 0.118 | 0.058 | 0.118 | GABA receptor agonist | |||
| 0.066 | 0.007 | 0.066 | Sphingosine kinase 1 inhibitor | |||
| 0.062 | 0.004 | 0.062 | Estrogen-related receptor beta antagonist | |||
| 0.064 | 0.006 | 0.064 | Delayed rectifier potassium channel blocker | |||
| 0.093 | 0.035 | 0.093 | Analgesic, opioid | |||
| 0.089 | 0.032 | 0.089 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.111 | 0.054 | 0.111 | Urease inhibitor | |||
| 0.074 | 0.018 | 0.119 | Leukotriene B4 antagonist | 0.119 0.007 CID_154699617 | CID_154699617 | |
| 0.087 | 0.032 | 0.087 | Carbonic anhydrase V inhibitor | |||
| 0.074 | 0.019 | 0.131 | Factor IXa inhibitor | 0.131 0.005 CID_154699617 | CID_154699617 | |
| 0.087 | 0.033 | 0.087 | Calcium channel L-type blocker | |||
| 0.062 | 0.008 | 0.062 | Potassium channel Kv1.1 blocker | |||
| 0.064 | 0.011 | 0.064 | Liver X receptor alpha agonist | |||
| 0.057 | 0.004 | 0.057 | Retinoid X alpha receptor antagonist | |||
| 0.063 | 0.009 | 0.069 | Guanylate cyclase inhibitor | 0.069 0.005 CID_154699617 | CID_154699617 | |
| 0.063 | 0.01 | 0.063 | Nicotinic acid receptor agonist | |||
| 0.1 | 0.047 | 0.1 | Potassium channel activator | |||
| 0.208 | 0.155 | 0.208 | Thyroid hormone antagonist | |||
| 0.057 | 0.005 | 0.057 | CF transmembrane conductance regulator antagonist | |||
| 0.058 | 0.006 | 0.058 | Liver X receptor beta antagonist | |||
| 0.068 | 0.016 | 0.068 | Leukotriene C antagonist | |||
| 0.118 | 0.067 | 0.118 | Proteasome inhibitor | |||
| 0.125 | 0.074 | 0.125 | Antibacterial (Helicobacter pylori) | |||
| 0.083 | 0.032 | 0.083 | Secretase beta inhibitor | |||
| 0.074 | 0.023 | 0.074 | Transcription factor RelA inhibitor | |||
| 0.065 | 0.015 | 0.065 | NMDA receptor subunit 3A antagonist | |||
| 0.161 | 0.111 | 0.161 | MAP kinase kinase 5 inhibitor | |||
| 0.057 | 0.007 | 0.057 | MAP3K5 inhibitor | |||
| 0.085 | 0.035 | 0.085 | HIV-1 integrase inhibitor | |||
| 0.119 | 0.069 | 0.233 | Alkylator | 0.233 0.019 CID_154699617 | CID_154699617 | |
| 0.106 | 0.057 | 0.106 | MAO B inhibitor | |||
| 0.072 | 0.023 | 0.072 | Heme oxygenase stimulant | |||
| 0.053 | 0.003 | 0.053 | Estrogen-related receptor gamma antagonist | |||
| 0.122 | 0.073 | 0.122 | MAO inhibitor | |||
| 0.151 | 0.103 | 0.151 | Death-associated protein kinase 2 inhibitor | |||
| 0.071 | 0.024 | 0.071 | Bombesin 3 receptor antagonist | |||
| 0.146 | 0.099 | 0.146 | Antipruritic | |||
| 0.082 | 0.035 | 0.082 | Carbonic anhydrase VA inhibitor | |||
| 0.069 | 0.022 | 0.069 | Glucosylceramidase inhibitor | |||
| 0.06 | 0.014 | 0.06 | Progesterone antagonist | |||
| 0.061 | 0.015 | 0.061 | 5-Alpha-reductase inhibitor | |||
| 0.076 | 0.031 | 0.076 | Exportin-1 inhibitor | |||
| 0.082 | 0.037 | 0.082 | Vanilloid 4 agonist | |||
| 0.075 | 0.029 | 0.14 | Neuraminidase (influenza) inhibitor | 0.14 0.008 CID_154699617 | CID_154699617 | |
| 0.061 | 0.016 | 0.061 | Oxytocin agonist | |||
| 0.081 | 0.036 | 0.081 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.071 | 0.027 | 0.071 | Cyclin D1 inhibitor | |||
| 0.062 | 0.018 | 0.062 | Purinergic P2Y antagonist | 0.045 0.031 CID_154699617 | ||
| 0.078 | 0.034 | 0.078 | Dopamine D1 antagonist | |||
| 0.076 | 0.032 | 0.076 | Potassium channel (ATP-sensitive) blocker | |||
| 0.077 | 0.034 | 0.077 | Leukotriene antagonist | 0.072 0.038 CID_154699617 | ||
| 0.068 | 0.025 | 0.068 | Alpha tubulin antagonist | |||
| 0.057 | 0.014 | 0.057 | GABA B receptor antagonist | |||
| 0.051 | 0.008 | 0.051 | Vanilloid 3 antagonist | |||
| 0.172 | 0.13 | 0.381 | Vasodilator | 0.381 0.026 CID_154699617 | CID_154699617 | |
| 0.055 | 0.013 | 0.055 | Glucocorticoid antagonist | |||
| 0.069 | 0.027 | 0.069 | Beta 1 adrenoreceptor antagonist | |||
| 0.069 | 0.027 | 0.069 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.054 | 0.013 | 0.054 | Farnesoid X receptor agonist | |||
| 0.093 | 0.052 | 0.093 | NMDA receptor antagonist | |||
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR4) antagonist | |||
| 0.047 | 0.006 | 0.047 | Prostaglandin EP2 agonist | 0.025 0.015 CID_154699617 | ||
| 0.106 | 0.065 | 0.106 | Falcipain 3 inhibitor | |||
| 0.063 | 0.022 | 0.063 | Beta 2 adrenoreceptor antagonist | |||
| 0.09 | 0.049 | 0.09 | Myeloperoxidase inhibitor | |||
| 0.056 | 0.017 | 0.056 | Geranyltranstransferase inhibitor | |||
| 0.109 | 0.07 | 0.109 | Nav1.5 sodium channel blocker | |||
| 0.043 | 0.005 | 0.043 | Thyroid hormone agonist | |||
| 0.081 | 0.043 | 0.081 | NMDA 2 receptor antagonist | |||
| 0.073 | 0.035 | 0.073 | CDC25B inhibitor | |||
| 0.05 | 0.012 | 0.05 | Glutamate (mGluR8) agonist | |||
| 0.06 | 0.023 | 0.06 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.042 | 0.004 | 0.042 | Retinoid X gamma receptor antagonist | 0.027 0.019 CID_154699617 | ||
| 0.091 | 0.054 | 0.091 | Antineoplastic alkaloid | |||
| 0.05 | 0.013 | 0.05 | Fumarate hydratase inhibitor | 0.037 0.021 CID_154699617 | ||
| 0.055 | 0.02 | 0.055 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.135 | 0.099 | 0.135 | MAP kinase kinase 4 inhibitor | |||
| 0.043 | 0.008 | 0.043 | Glutamate (mGluR3) agonist | |||
| 0.044 | 0.01 | 0.044 | Cholesterol ester transfer protein antagonist | |||
| 0.062 | 0.027 | 0.062 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.058 | 0.024 | 0.058 | Topoisomerase II beta inhibitor | |||
| 0.094 | 0.06 | 0.156 | Uric acid excretion stimulant | 0.156 0.021 CID_154699617 | CID_154699617 | |
| 0.057 | 0.024 | 0.057 | CD45 antagonist | |||
| 0.037 | 0.003 | 0.037 | Retinoid X beta receptor antagonist | |||
| 0.059 | 0.026 | 0.059 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.048 | 0.015 | 0.048 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.076 | 0.044 | 0.076 | Potassium channel (Tandem pore domain) blocker | |||
| 0.037 | 0.004 | 0.037 | Retinoic acid gamma receptor agonist | |||
| 0.039 | 0.007 | 0.147 | Sodium/glucose cotransporter inhibitor | 0.147 0.002 CID_154699617 | CID_154699617 | |
| 0.037 | 0.005 | 0.037 | Retinoic acid receptor antagonist | 0.02 0.011 CID_154699617 | ||
| 0.086 | 0.054 | 0.086 | mTOR complex 2 inhibitor | |||
| 0.058 | 0.026 | 0.117 | Glucose-6-phosphate translocase inhibitor | 0.117 0.004 CID_154699617 | CID_154699617 | |
| 0.076 | 0.044 | 0.076 | Peroxisome proliferator-activated receptor gamma agonist | 0.059 0.058 CID_154699617 | ||
| 0.077 | 0.046 | 0.077 | Cathepsin G inhibitor | |||
| 0.048 | 0.017 | 0.048 | GABA uptake inhibitor | |||
| 0.132 | 0.101 | 0.132 | Sigma receptor agonist | |||
| 0.039 | 0.008 | 0.039 | 5-Alpha-reductase 2 inhibitor | |||
| 0.043 | 0.013 | 0.043 | Ceramide glucosyltransferase inhibitor | 0.043 0.013 CID_154699617 | ||
| 0.066 | 0.035 | 0.066 | Histone deacetylase SIRT3 inhibitor | |||
| 0.085 | 0.054 | 0.085 | Glutathione S-transferase inhibitor | |||
| 0.045 | 0.015 | 0.045 | Leukotriene C4 antagonist | |||
| 0.049 | 0.019 | 0.049 | Beta adrenoreceptor agonist | |||
| 0.042 | 0.013 | 0.042 | Prostaglandin agonist | |||
| 0.055 | 0.026 | 0.055 | Opioid mu receptor agonist | |||
| 0.05 | 0.02 | 0.05 | Glutamate (mGluR group III) antagonist | |||
| 0.034 | 0.005 | 0.034 | Retinoic acid alpha receptor antagonist | |||
| 0.162 | 0.133 | 0.409 | Platelet antagonist | 0.409 0.025 CID_154699617 | CID_154699617 | |
| 0.044 | 0.015 | 0.044 | Estrogen-related receptor alpha antagonist | |||
| 0.035 | 0.006 | 0.056 | Vanilloid 2 agonist | 0.056 0.002 CID_154699617 | CID_154699617 | |
| 0.037 | 0.009 | 0.126 | Sodium/glucose cotransporter 2 inhibitor | 0.126 0.002 CID_154699617 | CID_154699617 | |
| 0.033 | 0.005 | 0.033 | Retinoic acid beta receptor agonist | |||
| 0.066 | 0.038 | 0.066 | Prostaglandin F2 alpha antagonist | |||
| 0.108 | 0.08 | 0.108 | Calcium channel N-type blocker | |||
| 0.108 | 0.08 | 0.108 | Acetylcholine muscarinic antagonist | |||
| 0.039 | 0.011 | 0.039 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.035 0.014 CID_154699617 | ||
| 0.093 | 0.065 | 0.093 | MAP kinase kinase 1 inhibitor | |||
| 0.128 | 0.1 | 0.432 | Hemostatic | 0.432 0.006 CID_154699617 | CID_154699617 | |
| 0.086 | 0.058 | 0.086 | Calcium antagonist | |||
| 0.036 | 0.008 | 0.036 | Retinoic acid receptor agonist | 0.021 0.019 CID_154699617 | ||
| 0.032 | 0.005 | 0.075 | Ileal bile acid transport inhibitor | 0.075 0.003 CID_154699617 | CID_154699617 | |
| 0.117 | 0.091 | 0.117 | Calcium channel blocker | |||
| 0.074 | 0.048 | 0.074 | Epoxide hydrolase inhibitor | |||
| 0.038 | 0.013 | 0.055 | Uridine phosphorylase inhibitor | 0.055 0.007 CID_154699617 | CID_154699617 | |
| 0.033 | 0.007 | 0.033 | Prostaglandin F2 alpha agonist | |||
| 0.064 | 0.039 | 0.064 | Cannabinoid CB1 receptor agonist | |||
| 0.033 | 0.008 | 0.033 | Hedgehog signaling activator | |||
| 0.065 | 0.041 | 0.065 | 5 Hydroxytryptamine 3 agonist | |||
| 0.057 | 0.033 | 0.057 | Epithelial sodium channel blocker | |||
| 0.049 | 0.024 | 0.049 | Leukocyte elastase inhibitor | |||
| 0.038 | 0.014 | 0.038 | Vanilloid 4 antagonist | |||
| 0.036 | 0.012 | 0.036 | Liver X receptor alpha antagonist | |||
| 0.1 | 0.076 | 0.1 | Protein kinase C gamma inhibitor | |||
| 0.032 | 0.008 | 0.032 | 5-Alpha-reductase 1 inhibitor | |||
| 0.066 | 0.043 | 0.066 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.027 | 0.005 | 0.027 | Nicotinic acid receptor 1 antagonist | |||
| 0.032 | 0.01 | 0.032 | Estrone sulfatase inhibitor | |||
| 0.032 | 0.01 | 0.032 | Thymidine phosphorylase inhibitor | |||
| 0.081 | 0.059 | 0.081 | Thioredoxin reductase inhibitor | |||
| 0.042 | 0.02 | 0.042 | VCAM-1 antagonist | |||
| 0.042 | 0.02 | 0.042 | VCAM antagonist | |||
| 0.071 | 0.049 | 0.071 | Cannabinoid receptor antagonist | |||
| 0.032 | 0.01 | 0.032 | Nicotinic acid receptor 2 antagonist | |||
| 0.056 | 0.034 | 0.056 | Ornithine carbamoyltransferase inhibitor | |||
| 0.077 | 0.055 | 0.077 | Somatostatin 1 agonist | |||
| 0.043 | 0.021 | 0.043 | TRPM8 blocker | |||
| 0.044 | 0.022 | 0.044 | Dihydropteroate synthase inhibitor | |||
| 0.055 | 0.034 | 0.055 | Opioid agonist | |||
| 0.053 | 0.032 | 0.053 | CXC chemokine 1 receptor antagonist | |||
| 0.187 | 0.166 | 0.187 | Thyroid hormone beta antagonist | |||
| 0.081 | 0.061 | 0.081 | GABA A receptor agonist | |||
| 0.025 | 0.004 | 0.025 | Thromboxane A2 agonist | |||
| 0.067 | 0.047 | 0.067 | Purinergic P2X2 antagonist | |||
| 0.032 | 0.012 | 0.032 | Dopamine autoreceptor agonist | |||
| 0.025 | 0.005 | 0.04 | Antibiotic Anthracycline-like | 0.04 0.002 CID_154699617 | CID_154699617 | |
| 0.061 | 0.041 | 0.061 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.054 | 0.034 | 0.054 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.03 | 0.01 | 0.03 | Prostaglandin E2 agonist | |||
| 0.056 | 0.036 | 0.056 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.032 | 0.012 | 0.032 | CXC chemokine 2 receptor antagonist | |||
| 0.029 | 0.009 | 0.029 | Bombesin agonist | |||
| 0.059 | 0.039 | 0.059 | Botulinum neurotoxin type A inhibitor | |||
| 0.026 | 0.006 | 0.026 | Alpha 2a adrenoreceptor agonist | |||
| 0.039 | 0.02 | 0.039 | Opioid delta receptor agonist | |||
| 0.024 | 0.005 | 0.034 | Telomerase stimulant | 0.034 0.003 CID_154699617 | CID_154699617 | |
| 0.073 | 0.054 | 0.073 | Alpha 2a adrenoreceptor antagonist | |||
| 0.024 | 0.005 | 0.024 | CC chemokine 9 receptor antagonist | |||
| 0.058 | 0.039 | 0.076 | Lipocortins synthesis agonist | 0.076 0.016 CID_154699617 | CID_154699617 | |
| 0.025 | 0.006 | 0.025 | Purinergic P2Y1 antagonist | |||
| 0.072 | 0.053 | 0.072 | Nav1.8 sodium channel blocker | |||
| 0.051 | 0.033 | 0.051 | Potassium channel (Inward rectifier) activator | |||
| 0.027 | 0.009 | 0.027 | ICAM 1 antagonist | |||
| 0.051 | 0.033 | 0.051 | Bombesin 2 receptor antagonist | |||
| 0.03 | 0.012 | 0.03 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.05 | 0.032 | 0.085 | Carbonic anhydrase XIV inhibitor | 0.085 0.015 CID_154699617 | CID_154699617 | |
| 0.031 | 0.013 | 0.031 | Motilin receptor antagonist | |||
| 0.025 | 0.008 | 0.025 | Bombesin 3 receptor agonist | |||
| 0.034 | 0.018 | 0.034 | Liver X receptor antagonist | |||
| 0.049 | 0.032 | 0.049 | Potassium channel (ATP-sensitive) activator | |||
| 0.025 | 0.009 | 0.025 | Imidazoline I1 receptor antagonist | |||
| 0.035 | 0.019 | 0.035 | Catechol O-methyltransferase inhibitor | |||
| 0.06 | 0.044 | 0.06 | Cannabinoid CB1 receptor antagonist | |||
| 0.116 | 0.101 | 0.116 | Neurotrophic factor | 0.112 0.109 CID_154699617 | ||
| 0.038 | 0.022 | 0.038 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.058 | 0.043 | 0.078 | Prostaglandin EP2 antagonist | 0.078 0.028 CID_154699617 | CID_154699617 | |
| 0.023 | 0.007 | 0.023 | Alpha 2b adrenoreceptor agonist | |||
| 0.028 | 0.012 | 0.028 | Glutamate (mGluR1) agonist | |||
| 0.061 | 0.046 | 0.061 | Carbonic anhydrase inhibitor | 0.057 0.048 CID_154699617 | ||
| 0.063 | 0.048 | 0.063 | Fibroblast growth factor 2 antagonist | |||
| 0.04 | 0.026 | 0.04 | Membrane dipeptidase inhibitor | |||
| 0.075 | 0.06 | 0.099 | Interferon agonist | 0.099 0.029 CID_154699617 | CID_154699617 | |
| 0.037 | 0.022 | 0.037 | Phosphoglycerate kinase inhibitor | |||
| 0.067 | 0.053 | 0.067 | Amidase inhibitor | |||
| 0.053 | 0.038 | 0.193 | Heparanase inhibitor | 0.193 0.002 CID_154699617 | CID_154699617 | |
| 0.043 | 0.029 | 0.043 | Heme oxygenase inhibitor | |||
| 0.062 | 0.048 | 0.081 | Interferon inducer | 0.081 0.023 CID_154699617 | CID_154699617 | |
| 0.056 | 0.041 | 0.056 | Fatty acid synthase inhibitor | |||
| 0.018 | 0.005 | 0.018 | Retinoic acid beta receptor antagonist | |||
| 0.03 | 0.017 | 0.03 | Purinergic P2Y15 antagonist | |||
| 0.034 | 0.021 | 0.034 | Liver X receptor beta agonist | |||
| 0.043 | 0.03 | 0.043 | Nerve growth factor antagonist | |||
| 0.022 | 0.009 | 0.022 | Caspase 8 inhibitor | |||
| 0.018 | 0.004 | 0.018 | Retinoic acid receptor gamma antagonist | 0.011 0.009 CID_154699617 | ||
| 0.06 | 0.047 | 0.06 | NMDA receptor agonist | |||
| 0.041 | 0.028 | 0.041 | Erythropoietin receptor agonist | |||
| 0.033 | 0.02 | 0.033 | HCV NS5B polymerase inhibitor | |||
| 0.024 | 0.012 | 0.024 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.041 | 0.029 | 0.041 | Toll-Like receptor 2 agonist | 0.04 0.029 CID_154699617 | ||
| 0.046 | 0.034 | 0.046 | Adenosine deaminase inhibitor | 0.041 0.04 CID_154699617 | ||
| 0.024 | 0.013 | 0.027 | Leukotriene B4 receptor 2 antagonist | 0.027 0.011 CID_154699617 | CID_154699617 | |
| 0.058 | 0.046 | 0.112 | Neuraminidase inhibitor | 0.112 0.011 CID_154699617 | CID_154699617 | |
| 0.035 | 0.023 | 0.035 | RNA-directed RNA polymerase inhibitor | |||
| 0.019 | 0.008 | 0.019 | NMDA receptor phencyclidine site antagonist | |||
| 0.141 | 0.13 | 0.141 | Antimitotic | |||
| 0.051 | 0.04 | 0.051 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.015 | 0.005 | 0.015 | Thromboxane agonist | |||
| 0.02 | 0.009 | 0.02 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.048 | 0.038 | 0.048 | Prolyl endopeptidase inhibitor | |||
| 0.015 | 0.005 | 0.015 | Egl nine homolog 3 inhibitor | |||
| 0.018 | 0.008 | 0.018 | Purinergic P2Y1 agonist | |||
| 0.024 | 0.015 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.051 | 0.042 | 0.051 | Ribonucleotide reductase inhibitor | |||
| 0.037 | 0.027 | 0.037 | Diamine oxidase inhibitor | |||
| 0.058 | 0.048 | 0.058 | NMDA receptor glycine site agonist | |||
| 0.067 | 0.058 | 0.067 | Lipase inhibitor | |||
| 0.023 | 0.014 | 0.023 | Glutamate (mGluR1a) agonist | |||
| 0.042 | 0.033 | 0.042 | AICAR transformylase inhibitor | |||
| 0.038 | 0.029 | 0.038 | Urate transporter 1 inhibitor | |||
| 0.022 | 0.013 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.044 | 0.036 | 0.044 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.13 | 0.121 | 0.13 | LIM domain kinase 1 inhibitor | |||
| 0.013 | 0.006 | 0.013 | Thrombopoietin agonist | |||
| 0.029 | 0.021 | 0.029 | Thiazolidinedione | |||
| 0.054 | 0.046 | 0.054 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.041 | 0.033 | 0.041 | Opioid kappa receptor agonist | |||
| 0.02 | 0.012 | 0.02 | Integrin alphaVbeta1 antagonist | |||
| 0.054 | 0.046 | 0.054 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.051 | 0.044 | 0.051 | Thromboxane synthase inhibitor | |||
| 0.05 | 0.044 | 0.05 | Carbonic anhydrase II inhibitor | |||
| 0.035 | 0.028 | 0.035 | Glutamate (mGluR3) antagonist | |||
| 0.012 | 0.006 | 0.012 | Imidazoline I2 receptor antagonist | |||
| 0.027 | 0.021 | 0.027 | Endothelin receptor antagonist | |||
| 0.068 | 0.062 | 0.068 | Adenosine A3 receptor antagonist | |||
| 0.038 | 0.032 | 0.038 | Glutamate (mGluR1a) antagonist | |||
| 0.043 | 0.038 | 0.043 | Purinergic P2X4 antagonist | |||
| 0.138 | 0.133 | 0.138 | I kappa B kinase epsilon inhibitor | |||
| 0.011 | 0.006 | 0.011 | 2-Acylglycerol O-acyltransferase 2 inhibitor | |||
| 0.044 | 0.039 | 0.044 | Mineralocorticoid receptor antagonist | |||
| 0.032 | 0.026 | 0.032 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.037 | 0.032 | 0.037 | Histone deacetylase 8 inhibitor | |||
| 0.024 | 0.019 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.033 | 0.028 | 0.065 | Arginase inhibitor | 0.065 0.009 CID_154699617 | CID_154699617 | |
| 0.016 | 0.012 | 0.016 | Vitamin D receptor agonist | |||
| 0.013 | 0.009 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.034 | 0.03 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.054 | 0.049 | 0.054 | Acetylcholine M3 receptor antagonist | |||
| 0.031 | 0.027 | 0.031 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.048 | 0.044 | 0.048 | Cathepsin D inhibitor | |||
| 0.023 | 0.02 | 0.023 | Prostaglandin H2 antagonist | |||
| 0.032 | 0.029 | 0.032 | Tubulin agonist | |||
| 0.031 | 0.028 | 0.031 | Free fatty acid receptor 1 antagonist | |||
| 0.055 | 0.053 | 0.055 | Cannabinoid receptor agonist | |||
| 0.048 | 0.045 | 0.048 | Acetyl-CoA transferase inhibitor | |||
| 0.143 | 0.141 | 0.143 | Aryl hydrocarbon receptor agonist | |||
| 0.011 | 0.009 | 0.011 | Glutamate (mGluR6) agonist | |||
| 0.021 | 0.019 | 0.021 | Isoleucine-tRNA ligase inhibitor | |||
| 0.006 | 0.004 | 0.006 | Transcortin receptor antagonist | |||
| 0.061 | 0.059 | 0.061 | Protein kinase C alpha inhibitor | |||
| 0.015 | 0.014 | 0.015 | Thyroid hormone alpha agonist | |||
| 0.021 | 0.019 | 0.029 | Dopamine D1 agonist | 0.029 0.009 CID_154699617 | CID_154699617 | |
| 0.008 | 0.007 | 0.008 | Thyroid hormone beta agonist | |||
| 0.006 | 0.005 | 0.006 | CC chemokine 6 receptor agonist | |||
| 0.041 | 0.04 | 0.041 | Carbonic anhydrase VII inhibitor | |||
| 0.046 | 0.048 | 0.058 | Factor III inhibitor | 0.058 0.019 CID_154699617 | CID_154699617 | |
| 0.043 | 0.052 | 0.055 | Cytokine production stimulant | 0.055 0.019 CID_154699617 | CID_154699617 | |
| 0.007 | 0.017 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 CID_154699617 | CID_154699617 | |
| 0.039 | 0.052 | 0.085 | Aldose reductase inhibitor | 0.085 0.022 CID_154699617 | CID_154699617 | |
| 0.06 | 0.074 | 0.172 | Topoisomerase II alpha inhibitor | 0.172 0.019 CID_154699617 | CID_154699617 | |
| 0.035 | 0.056 | 0.052 | Carbonic anhydrase IX inhibitor | 0.052 0.041 CID_154699617 | CID_154699617 | |
| 0.022 | 0.044 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.013 CID_154699617 | CID_154699617 | |
| 0.013 | 0.038 | 0.022 | Corticosteroid-like | 0.022 0.014 CID_154699617 | CID_154699617 | |
| 0.026 | 0.065 | 0.099 | Phosphorylase inhibitor | 0.099 0.013 CID_154699617 | CID_154699617 | |
| 0.068 | 0.108 | 0.176 | Transcription factor NF kappa B stimulant | 0.176 0.012 CID_154699617 | CID_154699617 | |
| 0.025 | 0.065 | 0.056 | Carbonic anhydrase XII inhibitor | 0.056 0.035 CID_154699617 | CID_154699617 | |
| 0.045 | 0.09 | 0.242 | Antineoplastic antibiotic | 0.242 0.015 CID_154699617 | CID_154699617 | |
| 0.065 | 0.11 | 0.242 | Topoisomerase I inhibitor | 0.242 0.018 CID_154699617 | CID_154699617 | |
| 0.011 | 0.058 | 0.057 | Squalene synthetase inhibitor | 0.057 0.012 CID_154699617 | CID_154699617 | |
| 0.043 | 0.092 | 0.062 | Transcription factor AP-1 inhibitor | 0.062 0.041 CID_154699617 | CID_154699617 | |
| 0.013 | 0.066 | 0.07 | Protein 30S ribosomal subunit inhibitor | 0.07 0.005 CID_154699617 | CID_154699617 | |
| 0.028 | 0.088 | 0.054 | Microtubule stabilization | 0.054 0.022 CID_154699617 | CID_154699617 | |
| 0.027 | 0.089 | 0.063 | Neuraminidase (Influenza A) inhibitor | 0.063 0.011 CID_154699617 | CID_154699617 | |
| 0.03 | 0.103 | 0.431 | Selectin antagonist | 0.431 0.003 CID_154699617 | CID_154699617 | |
| 0.015 | 0.098 | 0.04 | Factor Xa inhibitor | 0.04 0.037 CID_154699617 | CID_154699617 | |
| 0.059 | 0.145 | 0.237 | Topoisomerase II inhibitor | 0.237 0.026 CID_154699617 | CID_154699617 | |
| 0.002 | 0.1 | 0.016 | Antibiotic Macrolide-like | 0.016 0.009 CID_154699617 | CID_154699617 | |
| 0.055 | 0.157 | 0.131 | ATPase (Vacuolar H+) inhibitor | 0.131 0.014 CID_154699617 | CID_154699617 | |
| 0.051 | 0.154 | 0.111 | Falcipain 2 inhibitor | 0.111 0.046 CID_154699617 | CID_154699617 | |
| 0.073 | 0.179 | 0.376 | Cell adhesion inhibitor | 0.376 0.006 CID_154699617 | CID_154699617 | |
| 0.052 | 0.157 | 0.113 | Falcipain inhibitor | 0.113 0.047 CID_154699617 | CID_154699617 | |
| 0.035 | 0.173 | 0.094 | Histone deacetylase stimulant | 0.094 0.032 CID_154699617 | CID_154699617 | |
| 0.035 | 0.173 | 0.094 | Histone deacetylase SIRT1 stimulant | 0.094 0.032 CID_154699617 | CID_154699617 | |
| 0.142 | 0.287 | 0.318 | Antiobesity | 0.318 0.104 CID_154699617 | CID_154699617 | |
| 0.019 | 0.167 | 0.088 | Antibiotic Aminoglycoside-like | 0.088 0.004 CID_154699617 | CID_154699617 | |
| 0.117 | 0.294 | 0.313 | Angiogenesis inhibitor | 0.313 0.086 CID_154699617 | CID_154699617 | |
| 0.017 | 0.21 | 0.124 | Protein 50S ribosomal subunit inhibitor | 0.124 0.009 CID_154699617 | CID_154699617 | |
| 0.007 | 0.237 | 0.028 | Motilin receptor agonist | 0.028 0.01 CID_154699617 | CID_154699617 | |
| 0.019 | 0.253 | 0.073 | Nitric oxide donor | 0.073 0.029 CID_154699617 | CID_154699617 | |
| 0.067 | 0.315 | 0.293 | Insulin secretagoues | 0.293 0.013 CID_154699617 | CID_154699617 | |
| 0.102 | 0.351 | 0.524 | Immunomodulator | 0.524 0.02 CID_154699617 | CID_154699617 | |
| 0.013 | 0.289 | 0.036 | Toll-Like receptor 4 agonist | 0.036 0.006 CID_154699617 | CID_154699617 | |
| 0.026 | 0.324 | 0.118 | DNA intercalator | 0.118 0.059 CID_154699617 | CID_154699617 | |
| 0.028 | 0.381 | 0.093 | Multidrug resistance-associated protein 1 inhibitor | 0.093 0.091 CID_154699617 | CID_154699617 | |
| 0.005 | 0.383 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.013 CID_154699617 | CID_154699617 | |
| 0.025 | 0.483 | 0.27 | Anticoagulant | 0.27 0.034 CID_154699617 | CID_154699617 | |
| 0.031 | 0.583 | 0.089 | T cell inhibitor | 0.089 0.04 CID_154699617 | CID_154699617 | |
| 0.01 | 0.612 | 0.14 | Cell adhesion molecule inhibitor | 0.14 0.017 CID_154699617 | CID_154699617 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |